Barbiturates: Central Nervous System Depressants
Barbiturates are CNS depressants that enhance GABAA receptor-mediated chloride influx, causing sedation, hypnosis, anesthesia, and at high doses, respiratory depression.
Historical Use
1900s–1960s: Sedatives, hypnotics, anticonvulsants, anesthesia induction.
Decline
- Narrow therapeutic index (lethal dose close to therapeutic).
- High physical dependence and withdrawal severity (seizures, delirium).
- Dangerous interactions with alcohol/opioids.
- Enzyme induction alters metabolism of other drugs.
Current Role
- Refractory status epilepticus (pentobarbital, thiopental).
- Neurocritical care: controlled coma for intracranial hypertension.
- Physician-assisted death (where legal: secobarbital, pentobarbital).
Replacements
Benzodiazepines (wider safety margin), Z-drugs, newer antiseizure medications.
Barbiturates remain a cautionary example of iatrogenic harm from inadequate safety profiling.
Drug Addiction - Related Articles
- Understanding Alcohol Abuse: Signs, Effects & Treatment
- Medications for Alcohol Use Disorder: FDA-Approved Options
- Understanding Substance Abuse Treatment: Benefits & Drawbacks
- Intervention Planning: A Guide to Helping Loved Ones
- Drug Detox Symptoms: What to Expect & How to Manage
- Navigating Recovery: Repairing Relationships with Alcoholism
- Alcoholism Rehabilitation: Treatments and Recovery Options
